The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Pollmauml;cher, T.
* Articles by Mullington, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Pollmauml;cher, T.
* Articles by Mullington, J.
Related Collections
* Schizophrenia Spectrum Disorders
* Other Neuroleptics
Am J Psychiatry 154:1763-1765, December 1997
© 1997 American Psychiatric Association


Brief Report

Plasma Levels of Cytokines and Soluble Cytokine Receptors During Treatment With Haloperidol

Thomas Pollmauml;cher, M.D., Dunja Hinze-Selch,, M.D., Thomas Fenzel, M.D., Thomas Kraus, M.D., Andreas Schuld, M.D., and Janet Mullington, Ph.D.

OBJECTIVE: Clozapine increases the levels of cytokines and soluble cytokine receptors. The authors investigated whether haloperidol has similar effects. METHOD: Rectal temperature, white blood cell counts, and plasma levels of cytokines and soluble cytokine receptors were assessed before and during 6 weeks of haloperidol treatment in 10 psychiatric patients. RESULTS: Haloperidol at mean doses of 7.0 mg/day (SD=3.4), 6.9 mg/day (SD=3.4), and 5.0 mg/day (SD=3.1) at the end of the 1st, 2nd, and 6th weeks of treatment, respectively, did not affect rectal temperature, white blood cell counts, or plasma level of interleukin-1 receptor antagonist, interleukin-6, tumor necrosis factor—alpha (TNF-{alpha}), soluble TNF receptor p55 or p75, or soluble interleukin-2 receptor. CONCLUSIONS: Haloperidol is unlikely to confound the results of studies investigating disease-related alterations in the levels of a broad range of cytokines and soluble cytokine receptors in schizophrenia. (Am J Psychiatry 1997; 154:1763–1765)




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
G. J. Paterson, Y. Ohashi, G. P. Reynolds, J. A. Pratt, and B. J. Morris
Selective increases in the cytokine, TNF{alpha}, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs
J Psychopharmacol, September 1, 2006; 20(5): 636 - 642.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1997 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org